The Outbreak That Came Back to Haunt One Sudanese Nurse
Author : Shivani Shinde | Published On : 12 Aug 2026
In January 2026, a measles and rubella catch-up campaign opened in Tawila, North Darfur. UNICEF had facilitated the delivery of 2.5 million doses into the Darfur states, with a further 4.1 million expected by early February, against a target of six million children.
For the health workers running the vaccination points, a campaign of that size carries an unusual kind of recognition. Some of the children in the queue are being vaccinated for the first time in their lives. Others were vaccinated before, in a different town, by someone who has since fled, and are being vaccinated again because there is no record that they were.
And some of them are the children a nurse remembers immunising the previous year, now sitting in a treatment ward with measles anyway.
What broke in between
Measles is the most contagious disease in routine circulation. The virus stays airborne in an enclosed space for up to two hours after an infected person has left it, and a person becomes infectious around four days before the rash that identifies them appears. Both facts mean the disease moves through a population well ahead of anyone's ability to see it moving.
Against that, the only real defence is population-level coverage. Roughly 95 per cent of a community needs two doses for transmission to stop. Below that threshold, measles does not simply become somewhat more common. It re-establishes itself.
Sudan crossed that line early in the war. A narrative review published in The Lancet Regional Health – Africa in March 2026 described the country as facing one of the most severe measles emergencies in recent decades, driven by the collapse of routine immunisation under conflict and displacement, alongside a sharp rise in children who have never received a first dose of any routine vaccine. Gavi has noted that more than 70 per cent of health facilities in affected areas stopped operating after fighting began in April 2023.
An earlier Lancet correspondence traced the sequence: confirmed clusters in South Kordofan and West Darfur in March 2023, then White Nile in April 2024, with insecurity and fuel shortages delaying verification each time.
Fuel shortages are the detail worth pausing on, because that is where a vaccination programme actually fails.
The cold chain, described plainly
A vaccine has to be held between roughly two and eight degrees Celsius from the moment it is manufactured to the moment it enters a child's arm. This is the cold chain, and its defining property is that failure is invisible and permanent. A vial that has warmed past its range looks exactly like a vial that has not. Potency, once lost, cannot be recovered.
So a cold chain is not really a refrigerator. It is a sequence: a cold room at a national store, a refrigerated truck, a district fridge, a cool box carried on the back of a motorbike, an ice pack replaced on schedule. Every link needs power. Most of those links, in Sudan, need diesel.
When the fuel stops, nothing dramatic happens. The fridge in a rural facility warms over a few hours. The stock inside it is now inert. Nobody knows until the children who received it start presenting with the disease it was supposed to prevent.
That is the specific shape of the heartbreak in a measles ward during conflict. It is not that the children were missed. Some of them were reached, correctly, by people doing the job properly, with a product that had already failed somewhere upstream.
The fix is unromantic. Solar-powered refrigeration units, which take the diesel dependency out of the chain entirely, are now being installed in facilities where grid electricity was never reliable. The Lancet review argued for exactly this: rebuilding temperature-stable systems with solar refrigeration, alongside rapid-response teams trained for conflict settings and fixed outreach points sited in displacement hubs rather than in the towns where clinics used to be.
Track, then reach
The response runs on a division of labour that is easy to describe and difficult to execute.
WHO holds the surveillance layer. Case-based reporting, laboratory confirmation, and the early-warning system that identifies which localities are seeing clusters and which are about to. That output is a list of places, ranked by urgency.
UNICEF holds supply and delivery. Procurement, the cold chain itself, and the last-mile logistics of getting a functioning vial into a locality that a truck cannot reach. Both agencies then run the campaign jointly with the federal and state ministries of health, with financing largely from Gavi, which has committed well over $100 million to immunisation in Sudan since the war began.
Neither half works alone. Surveillance without supply produces an accurate map of preventable deaths. Supply without surveillance produces vaccine delivered to the wrong district while an outbreak burns through the next one. The value of sustained immunisation work sits precisely in the join between them, which is also the part no photograph captures.
Around the measles rounds, the same teams move polio vaccine, vitamin A and deworming tablets, and screen for malnutrition while children are in front of them. Two recent polio rounds in Central and West Darfur reached more than 500,000 children under five.
The number that argues against fatalism
There is a version of this story that ends in resignation, and the evidence does not support it.
In July 2026, WHO and UNICEF published their annual global immunisation estimates. The headline was mixed: 57 countries reported major or disruptive measles outbreaks in the preceding year, and more than half of the world's zero-dose children live in fragile or conflict-affected states. Globally, an estimated 14.3 million children were classified as zero-dose in 2024, having received no dose of any routine vaccine. Syria's coverage fell sharply.
Sudan recorded one of the largest improvements in the world.
That finding is worth stating carefully, because it is easy to overclaim. It does not mean the crisis is resolving. It means coverage rose in a country that was, at the same time, hosting the largest displacement emergency on earth, which establishes something specific and useful: immunisation rates can recover during a war, if access expands. The variable is access, not the war.
For the nurse in the ward, that is a colder comfort than it sounds. The children in front of her are still there. But the thing she is being asked to believe is not that the situation is improving in general. It is that a campaign round, run properly, with vaccine that arrived cold, measurably reduces the number of children who will be in that ward next year.
What a round of vaccination actually buys
Roughly six million children targeted in the Darfur states. Two and a half million doses moved, then four million more. Vaccination points staffed by people who will do this again in six months, because a catch-up campaign is not a substitute for routine immunisation; it is a way of buying time until routine services can be rebuilt.
None of that is a resolution. It is maintenance, performed under conditions where maintenance is the whole battle.
Sudan has more than 33 million people needing humanitarian assistance, including 21 million who require health services. Within that figure sits a smaller, more tractable one: the number of children who are one functioning fridge, one delivered consignment and one staffed morning away from not getting measles at all. The wider response for children in crisis is built around that distinction, and so is the emergency operation inside Sudan.
